Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2022-12-01 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges regarding a shareholder's request for loss of securities and issuance of a duplicate share certificate. It references compliance with SEBI regulations and includes details about the shareholder and share certificates. There are no financial statements, earnings data, management discussion, or other report content. The document is an official regulatory announcement related to share certificate handling and shareholder information, not a financial report or meeting material. It is a regulatory filing informing exchanges of a corporate action related to securities.
2022-12-01 English
Related Party Transaction
Regulatory Filings Classification · 95% confidence The document is a disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides detailed tabular data on related party transactions for the half year ended September 30, 2022. This type of disclosure is a regulatory filing required by stock exchanges and securities regulators to ensure transparency of transactions between the company and its related parties. The document is not an annual or interim report, audit report, earnings release, or any other report type but a specific regulatory disclosure. It is not merely an announcement of a report but contains substantive data on related party transactions. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-11-28 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on November 14, 2022, discussing the unaudited financial results for the quarter and half-year ended September 30, 2022. It includes management commentary on financial performance, business updates, and a Q&A session with analysts. The presence of detailed financial discussion, management remarks, and Q&A is characteristic of a Call Transcript (CT). The document is not a brief earnings release (ER) since it contains the full transcript, nor is it an Annual or Interim Report. Therefore, the appropriate classification is Call Transcript (CT).
2022-11-22 English
Press Release
Regulatory Filings Classification · 90% confidence The document is a press release announcing the USFDA approval of a pharmaceutical product by Strides Pharma Science Limited. It is addressed to stock exchanges and includes details about the product, company background, and contact information. The document does not contain financial statements, detailed financial analysis, or regulatory filings. It is a corporate announcement about a product approval, which fits best under the category of a Capital/Financing Update (CAP) as it relates to company operations and market product approvals impacting business prospects. However, since it is primarily a press release about product approval and not about fundraising or capital structure changes, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories. The document length is short (4204 characters), and it is not an annual or quarterly report, nor a call transcript or management report. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2022-11-18 English
Loss of share certificate
Regulatory Filings
2022-11-17 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of an earnings call for the quarter and half year ended September 30, 2022. It references the financial results approved by the board and provides a link to the audio recording of the earnings call. The document does not contain the financial results themselves, nor detailed financial data or analysis, but rather is an announcement about the availability of the earnings call recording. According to the classification rules, such a document is best classified as a Call Transcript (CT) type, since it pertains to the earnings call content. However, since this is only an announcement of the audio recording and not the transcript itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory announcement about the earnings call recording availability, not the transcript or the earnings release itself. The document length is short (1396 characters), and it mainly serves to inform about the recording link, not the report or transcript content. Therefore, the best fit is Regulatory Filings (RNS).
2022-11-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.